COMMENTARY

• COMMENTARY／Industry Should Guarantee Development of Innovative Drugs and Use of More Generics
  January 19, 2009

• COMMENTARY／Aiming at Further Growth beyond Global Recession
  January 12, 2009

• COMMENTARY／Rule to Restrict Participation in CDFS Committee Deliberations Needs Continued Validation
  January 5, 2009

• COMMENTARY／Will Economic Incentives for Med. Institutions Be Effective to Promote Use of Generics?
  December 22, 2008

• Commentary／Issue of Online Sales of OTC Drugs at Standstill
  December 15, 2008

• COMMENTARY／Toyota, NEC Start Direct Inspection, Payment of Medical Bills
  December 8, 2008

• COMMENTARY／Will VITAL KSK Become Core of Alliance of Regional Wholesalers?
  December 8, 2008

• SURVEY／DPP-4 Inhibitors May Decrease Consumption of SUs
  December 1, 2008

• COMMENTARY／Thinking about Why Megapharmas Are Closing Research Labs in Japan
  November 24, 2008

• COMMENTARY／Marriage of Nos. 1 and 2 Wholesalers Creates Sensation in Market
  November 3, 2008

• COMMENTARY／Competition Intensifies for Development of DPP-4 Inhibitors
  September 22, 2008

• COMMENTARY／Yamato Searches for a Way to Start Generics Distribution Business
  September 22, 2008

• COMMENTARY／Reform of Ethical Drug Distribution Practices
  September 1, 2008

• COMMENTARY／Gov't to Cut Social Security Spending by \220 Bil by Promoting Use of Generics
  August 25, 2008

• COMMENTARY／Development Race for RNAi Therapeutics Heating Up in Japan
  August 4, 2008

• COMMENTARY 4 articles
  July 28, 2008

• COMMENTARY／Industry Needs More Creative Thinking: NHI Pricing System Reform
  July 21, 2008

• COMMENTARY／Will Fiscal Rehabilitation Policy Be Maintained?
  July 7, 2008

• COMMENTARY／Daiichi Sankyo Surprises the World by Announcing Acquisition of Ranbaxy
  June 30, 2008

• Pharmaceutical Partnerships in Japan for Regulatory and Commercial Success
  June 30, 2008

ページ

• « 先頭
• ‹ Prev
• …
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• …
• Next ›
• 最終 »